What is IROA Technologies?
Founded in 2010, IROA Technologies specializes in simplifying metabolomics research through innovative solutions. The company offers a comprehensive suite of products, including stable isotope-labeled biochemical standards, libraries for mass spectrometry, and advanced data analytics software. Their automated metabolomics workflow is designed to enhance the accuracy and reproducibility of mass spectrally based measurements, ensuring consistent results across different batches and laboratories. IROA Technologies primarily targets clients involved in clinical metabolomics, aiming to facilitate the identification of biomarkers and the characterization of phenotypes.
How much funding has IROA Technologies raised?
IROA Technologies has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in IROA Technologies
PPP
Public-Private Partnership
What's next for IROA Technologies?
The recent substantial expansion capital infusion suggests IROA Technologies is poised for significant scaling and market penetration. As a company operating at a significant Series B/C stage, this funding is likely to be strategically deployed towards enhancing their product development, expanding their sales and marketing efforts, and potentially forging new partnerships within the life sciences and clinical research industries. The focus on simplifying metabolomics research indicates a strong market need for accessible and accurate analytical tools, a demand IROA Technologies is well-positioned to meet.
See full IROA Technologies company page
